Type 1 diabetes intervention trials : what have we learned? A critical review of selected intervention trials
Developing therapies to stop or slow the immune destruction of islets has been a goal of investigators in type 1 diabetes for several decades. This review of clinical interventions in patients with type 1 diabetes indicates both negative and positive outcomes with a variety of different therapeutic...
Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 104(2002), 2 vom: 06. Aug., Seite 97-104 |
---|---|
1. Verfasser: | |
Format: | Aufsatz |
Sprache: | English |
Veröffentlicht: |
2002
|
Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.) |
Schlagworte: | Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review C-Peptide Insulin |